Which has higher earnings and valuation, MDXG or RCEL?

MiMedx Group has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MiMedx Group $418.63M 1.31 $48.58M $0.20 18.40 Avita Medical $71.61M 1.86 -$48.59M -$1.57 N/A

Avita Medical (RCEL) Competitors

$4.33 0.00 (0.00%)

Closing price 05/29/2026 04:00 PM Eastern

Extended Trading

$4.29 -0.04 (-1.02%)

As of 05/29/2026 05:53 PM Eastern

Compare

RCEL vs. MDXG, BBNX, KIDS, DCTH, and CLPT

Should you buy Avita Medical stock or one of its competitors? MarketBeat compares Avita Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Avita Medical include MiMedx Group (MDXG), Beta Bionics (BBNX), OrthoPediatrics (KIDS), Delcath Systems (DCTH), and ClearPoint Neuro (CLPT). These companies are all part of the "medical equipment" industry.

How does Avita Medical compare to MiMedx Group?

MiMedx Group (NASDAQ:MDXG) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends.

MiMedx Group has a net margin of 7.88% compared to Avita Medical's net margin of -62.67%. MiMedx Group's return on equity of 21.03% beat Avita Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiMedx Group	7.88%	21.03%	15.92%
Avita Medical	-62.67%	N/A	-78.92%

MiMedx Group currently has a consensus price target of $8.50, indicating a potential upside of 130.98%. Avita Medical has a consensus price target of $7.25, indicating a potential upside of 67.44%. Given MiMedx Group's stronger consensus rating and higher possible upside, equities research analysts plainly believe MiMedx Group is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiMedx Group	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

79.2% of MiMedx Group shares are held by institutional investors. Comparatively, 27.7% of Avita Medical shares are held by institutional investors. 2.5% of MiMedx Group shares are held by company insiders. Comparatively, 2.8% of Avita Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

MiMedx Group has a beta of 1.48, meaning that its stock price is 48% more volatile than the broader market. Comparatively, Avita Medical has a beta of 1.87, meaning that its stock price is 87% more volatile than the broader market.

MiMedx Group has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiMedx Group	$418.63M	1.31	$48.58M	$0.20	18.40
Avita Medical	$71.61M	1.86	-$48.59M	-$1.57	N/A

In the previous week, MiMedx Group and MiMedx Group both had 1 articles in the media. MiMedx Group's average media sentiment score of 1.87 beat Avita Medical's score of 0.77 indicating that MiMedx Group is being referred to more favorably in the media.

Company	Overall Sentiment
MiMedx Group	Very Positive
Avita Medical	Positive

Summary

MiMedx Group beats Avita Medical on 12 of the 15 factors compared between the two stocks.

How does Avita Medical compare to Beta Bionics?

Beta Bionics (NASDAQ:BBNX) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

In the previous week, Beta Bionics had 4 more articles in the media than Avita Medical. MarketBeat recorded 5 mentions for Beta Bionics and 1 mentions for Avita Medical. Avita Medical's average media sentiment score of 0.77 beat Beta Bionics' score of 0.15 indicating that Avita Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Beta Bionics	Neutral
Avita Medical	Positive

Avita Medical has lower revenue, but higher earnings than Beta Bionics. Beta Bionics is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beta Bionics	$100.25M	5.39	-$73.20M	-$1.51	N/A
Avita Medical	$71.61M	1.86	-$48.59M	-$1.57	N/A

Beta Bionics has a beta of 3.4, suggesting that its stock price is 240% more volatile than the broader market. Comparatively, Avita Medical has a beta of 1.87, suggesting that its stock price is 87% more volatile than the broader market.

Beta Bionics has a net margin of -60.27% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat Beta Bionics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beta Bionics	-60.27%	-23.00%	-20.55%
Avita Medical	-62.67%	N/A	-78.92%

Beta Bionics presently has a consensus target price of $19.70, indicating a potential upside of 62.54%. Avita Medical has a consensus target price of $7.25, indicating a potential upside of 67.44%. Given Avita Medical's higher probable upside, analysts plainly believe Avita Medical is more favorable than Beta Bionics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beta Bionics	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

27.7% of Avita Medical shares are owned by institutional investors. 5.3% of Beta Bionics shares are owned by company insiders. Comparatively, 2.8% of Avita Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Beta Bionics beats Avita Medical on 11 of the 17 factors compared between the two stocks.

How does Avita Medical compare to OrthoPediatrics?

OrthoPediatrics (NASDAQ:KIDS) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and valuation.

OrthoPediatrics has a net margin of -16.31% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-16.31%	-7.01%	-4.86%
Avita Medical	-62.67%	N/A	-78.92%

OrthoPediatrics currently has a consensus price target of $24.44, indicating a potential upside of 42.37%. Avita Medical has a consensus price target of $7.25, indicating a potential upside of 67.44%. Given Avita Medical's higher probable upside, analysts plainly believe Avita Medical is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, OrthoPediatrics had 3 more articles in the media than Avita Medical. MarketBeat recorded 4 mentions for OrthoPediatrics and 1 mentions for Avita Medical. OrthoPediatrics' average media sentiment score of 0.99 beat Avita Medical's score of 0.77 indicating that OrthoPediatrics is being referred to more favorably in the media.

Company	Overall Sentiment
OrthoPediatrics	Positive
Avita Medical	Positive

69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 27.7% of Avita Medical shares are owned by institutional investors. 31.8% of OrthoPediatrics shares are owned by insiders. Comparatively, 2.8% of Avita Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

OrthoPediatrics has a beta of 1.03, meaning that its stock price is 3% more volatile than the broader market. Comparatively, Avita Medical has a beta of 1.87, meaning that its stock price is 87% more volatile than the broader market.

OrthoPediatrics has higher revenue and earnings than Avita Medical. OrthoPediatrics is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	1.87	-$39.65M	-$1.68	N/A
Avita Medical	$71.61M	1.86	-$48.59M	-$1.57	N/A

Summary

OrthoPediatrics beats Avita Medical on 12 of the 17 factors compared between the two stocks.

How does Avita Medical compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk, media sentiment and earnings.

Delcath Systems has a net margin of 0.62% compared to Avita Medical's net margin of -62.67%. Delcath Systems' return on equity of 0.51% beat Avita Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.62%	0.51%	0.46%
Avita Medical	-62.67%	N/A	-78.92%

61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 27.7% of Avita Medical shares are held by institutional investors. 19.4% of Delcath Systems shares are held by insiders. Comparatively, 2.8% of Avita Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Delcath Systems has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$85.23M	4.37	$2.70M	$0.01	1,078.00
Avita Medical	$71.61M	1.86	-$48.59M	-$1.57	N/A

In the previous week, Delcath Systems had 1 more articles in the media than Avita Medical. MarketBeat recorded 2 mentions for Delcath Systems and 1 mentions for Avita Medical. Delcath Systems' average media sentiment score of 0.94 beat Avita Medical's score of 0.77 indicating that Delcath Systems is being referred to more favorably in the media.

Company	Overall Sentiment
Delcath Systems	Positive
Avita Medical	Positive

Delcath Systems presently has a consensus target price of $22.50, suggesting a potential upside of 108.72%. Avita Medical has a consensus target price of $7.25, suggesting a potential upside of 67.44%. Given Delcath Systems' stronger consensus rating and higher possible upside, equities analysts plainly believe Delcath Systems is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.43
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Delcath Systems has a beta of 0.54, suggesting that its stock price is 46% less volatile than the broader market. Comparatively, Avita Medical has a beta of 1.87, suggesting that its stock price is 87% more volatile than the broader market.

Summary

Delcath Systems beats Avita Medical on 15 of the 16 factors compared between the two stocks.

How does Avita Medical compare to ClearPoint Neuro?

Avita Medical (NASDAQ:RCEL) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

Avita Medical has a net margin of -62.67% compared to ClearPoint Neuro's net margin of -71.57%. Avita Medical's return on equity of 0.00% beat ClearPoint Neuro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
ClearPoint Neuro	-71.57%	-140.96%	-36.98%

Avita Medical presently has a consensus price target of $7.25, indicating a potential upside of 67.44%. ClearPoint Neuro has a consensus price target of $18.00, indicating a potential upside of 42.07%. Given Avita Medical's higher probable upside, research analysts plainly believe Avita Medical is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

ClearPoint Neuro has lower revenue, but higher earnings than Avita Medical. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	1.86	-$48.59M	-$1.57	N/A
ClearPoint Neuro	$36.97M	10.28	-$25.54M	-$1.01	N/A

In the previous week, ClearPoint Neuro had 6 more articles in the media than Avita Medical. MarketBeat recorded 7 mentions for ClearPoint Neuro and 1 mentions for Avita Medical. Avita Medical's average media sentiment score of 0.77 beat ClearPoint Neuro's score of 0.31 indicating that Avita Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Avita Medical	Positive
ClearPoint Neuro	Neutral

Avita Medical has a beta of 1.87, meaning that its stock price is 87% more volatile than the broader market. Comparatively, ClearPoint Neuro has a beta of 1.31, meaning that its stock price is 31% more volatile than the broader market.

27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are owned by institutional investors. 2.8% of Avita Medical shares are owned by insiders. Comparatively, 6.9% of ClearPoint Neuro shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Avita Medical beats ClearPoint Neuro on 8 of the 15 factors compared between the two stocks.

Get Avita Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RCEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RCEL vs. The Competition

Export

Metric	Avita Medical	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$133.28M	$3.02B	$6.41B	$12.57B
Dividend Yield	N/A	1.84%	2.68%	5.31%
P/E Ratio	-2.76	18.29	21.61	26.27
Price / Sales	1.86	342.33	561.77	114.93
Price / Cash	N/A	55.97	27.44	37.60
Price / Book	-7.87	4.06	10.04	6.86
Net Income	-$48.59M	$75.85M	$3.56B	$337.26M
7 Day Performance	-5.46%	2.83%	2.82%	3.58%
1 Month Performance	N/A	N/A	N/A	-0.79%
1 Year Performance	-22.82%	32.89%	37.62%	39.67%

Avita Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RCEL Avita Medical	2.6119 of 5 stars	$4.33 flat	$7.25 +67.4%	-22.8%	$133.28M	$71.61M	N/A	130
MDXG MiMedx Group	4.0055 of 5 stars	$3.63 +0.3%	$8.50 +134.2%	-43.1%	$540.69M	$418.63M	18.15	870
BBNX Beta Bionics	3.2206 of 5 stars	$11.82 flat	$20.00 +69.2%	-29.5%	$526.70M	$100.25M	N/A	294	Gap Down
KIDS OrthoPediatrics	2.8769 of 5 stars	$18.37 flat	$24.44 +33.1%	-14.9%	$471.74M	$236.35M	N/A	200	Positive News
DCTH Delcath Systems	2.2317 of 5 stars	$11.02 flat	$22.50 +104.2%	-32.9%	$380.41M	$85.23M	1,102.00	60

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RCEL) was last updated on 6/1/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Avita Medical (RCEL) Competitors

RCEL vs. MDXG, BBNX, KIDS, DCTH, and CLPT

How does Avita Medical compare to MiMedx Group?

Summary

How does Avita Medical compare to Beta Bionics?

Summary

How does Avita Medical compare to OrthoPediatrics?

Summary

How does Avita Medical compare to Delcath Systems?

Summary

How does Avita Medical compare to ClearPoint Neuro?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL vs. The Competition

Avita Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Avita Medical (RCEL) Competitors

RCEL vs. MDXG, BBNX, KIDS, DCTH, and CLPT

How does Avita Medical compare to MiMedx Group?

Is MDXG or RCEL more profitable?

Do analysts prefer MDXG or RCEL?

Do insiders & institutionals believe in MDXG or RCEL?

Which has more volatility and risk, MDXG or RCEL?

Which has higher earnings and valuation, MDXG or RCEL?

Does the media prefer MDXG or RCEL?

Summary

How does Avita Medical compare to Beta Bionics?

Does the media prefer BBNX or RCEL?

Which has better valuation and earnings, BBNX or RCEL?

Which has more volatility & risk, BBNX or RCEL?

Is BBNX or RCEL more profitable?

Do analysts recommend BBNX or RCEL?

Do institutionals and insiders believe in BBNX or RCEL?

Summary

How does Avita Medical compare to OrthoPediatrics?

Is KIDS or RCEL more profitable?

Do analysts rate KIDS or RCEL?

Does the media prefer KIDS or RCEL?

Do insiders and institutionals believe in KIDS or RCEL?

Which has more volatility and risk, KIDS or RCEL?

Which has preferable earnings & valuation, KIDS or RCEL?

Summary

How does Avita Medical compare to Delcath Systems?

Is DCTH or RCEL more profitable?

Do institutionals and insiders hold more shares of DCTH or RCEL?

Which has stronger earnings and valuation, DCTH or RCEL?

Does the media refer more to DCTH or RCEL?

Do analysts rate DCTH or RCEL?

Which has more risk and volatility, DCTH or RCEL?

Summary

How does Avita Medical compare to ClearPoint Neuro?

Is RCEL or CLPT more profitable?

Do analysts recommend RCEL or CLPT?

Which has preferable earnings & valuation, RCEL or CLPT?

Does the media favor RCEL or CLPT?

Which has more volatility and risk, RCEL or CLPT?

Do insiders and institutionals believe in RCEL or CLPT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL vs. The Competition

Avita Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools